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Gender differences in rehabilitation outcomes among older Chinese patients
JKH Luk, PKC Chiu, LW Chu
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
Introduction: At present, male and female patients undergo the same programme in geriatric rehabilitation. 
During literature review, we cannot find any study concerning whether there are gender differences in geriatric 
rehabilitation. This study investigated the relationship between gender and rehabilitation outcomes of older 
Chinese patients. 
Methods: It was a retrospective study carried out in two geriatric rehabilitation hospitals in Hong Kong. Absolute 
functional and motor gains were expressed as Barthel Index (BI) efficacy and Elderly Mobility Scale (EMS) 
efficacy. BI and EMS efficiency were efficacy divided by the length of stay. Satisfactory motor and functional 
outcomes were defined as discharge EMS ≥15 and BI ≥75. 
Results: A total of 1795 patients were studied. Compared with men, women had higher BI but lower EMS on 
admission and discharge. EMS and BI efficacy and efficiency were similar in both sexes. Female gender was a 
significant independent negative predictor for satisfactory motor outcome (P=0.0002) but a positive predictor 
for functional outcome (P=0.0007). Other independent predictors for satisfactory motor outcome were: age 
(P<0.001); urinary incontinence (P=0.0049); living at home (P=0.0056); admission EMS (P<0.001); admission BI 
(P=0.044). Other predictors for satisfactory functional outcome were: age (P=0.009); infection other than chest 
(P=0.047); urinary incontinence (P<0.001); Mini-Mental State Examination (P=0.0004); admission EMS (P=0.005); 
BI (P<0.001). 
Conclusion: Women achieved a better functional outcome but a poorer motor outcome on discharge. Female 
gender was a positive predictor for functional outcome but a negative factor for motor outcome. Our results 
seem to suggest that a gender-tailored rehabilitation programme is needed to foster the motor and functional 
independence of older men and women.
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Distinctive functions of methionine aminopeptidase II in embryonic haematopoiesis in 
zebrafish embryos
ACH Ma1, RHC Lin1, MIS Chung1, D Yang2, RHS Liang1, AYH Leung1
1Department of Medicine, The University of Hong Kong, Hong Kong; 
2Department of Chemistry, The University of Hong Kong, Hong Kong
Introduction: Methionine aminopeptidase 2 (MetAP-2) is known to be the target of an anti-angiogenesis 
compound fumagillin and has been investigated for its robust expression in human cancers and its anti-
proliferative effects on endothelial cells. Together with a related member MetAP-1, they are proteases which 
remove the initiator NH2-terminal methionine from the nascent peptides during protein translation. Despite 
its pathogenetic significance in cancers, the physiological role of MetAP-2, particularly during embryonic 
development, has remained unclear. In this study, we made use of the zebrafish model and investigated 
the expression and functions of MetAP-2 during embryonic development, with particular reference to 
haematopoiesis. 
Methods and Results: We injected a morpholino (4.5 ng) targeting at the splice-site junction of MetAP-2 gene 
into zebrafish embryos at 1-4 cell stage (referred as MetAP-2MO embryos). Molecular targeting was confirmed by 
real-time polymerase chain reaction (RT-PCR). Modulation of MetAP-2 activity was shown by a shift of isoelectric 
point of GAPDH in 2-dimensional electrophoresis. The MetAP-2MO embryos exhibited a kinked tail with altered 
somitic patterning and specific changes in haematopoietic gene expression as shown by both whole-mount 
in-situ hybridisation and RT-PCR. The latter included down-regulation of scl and lmo2 (primitive HSC) and up-
regulation of mpo (primitive myeloid cells) at 18 hpf, as well as up-regulation of c-myb and runx1 (definitive 
HSC) at 36 hpf. Importantly, the haematopoietic phenotype could be rescued by co-injecting the embryos with 
MetAP-2 mRNA and re-capitulated by treating the embryos with fumagillin and its analogues. Mechanistically, 
the MetAP-2MO embryos exhibited reduced camodulin kinase II (CaMKII) activity and the haematopoietic 
phenotypes could be rescued by CaMKII mRNA and recapitulated by a CaMKII inhibitor. Treating the embryos 
with inhibitors of RhoA and JNK also recapitulated some of the haematopoietic phenotypes. The canonical Wnt 
pathway, characterised by β-catenin signalling, was not affected. 
Conclusion: We demonstrated that MetAP-2 knock-down resulted in down-regulation of scl and lmo2 and 
up-regulation of mpo, c-myb and runx1. Treating the embryos with a specific MetAP-2 inhibitor fumagillin 
and its structural analogues recapitulated these changes in haematopoietic gene expression, supporting 
the proposition that MetAP-2 is involved in the regulation of embryonic haematopoiesis. Mechanistically, 
the haematopoietic phenotypes were linked to the modulation of non-canonical but not the canonical Wnt 
pathways. These observations have provided us with important insights to the regulation of embryonic 
haematopoiesis.
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